Skip to main content
. 2014 Jul 4;8(4):791–806. doi: 10.1177/1932296814536271

Table 3.

Number of Hypotheses per Participant and Scenario.

Participant (PI scenario) Number of Stage 1–compliant hypotheses Number of final hypotheses in reduced dynamic envelope
S1 (I) 1106 549
S1 (No I) 1571 535
S2 (I) 1017 621
S2 (No I) 1115 894

(I), scenario where plasma insulin (PI) assays are available in Stage 1 identification; (No I), scenario where PI assays are unavailable.